Clinical Trials Directory

Trials / Unknown

UnknownNCT00958945

Retrospective Chart Analysis in the Effective Use of FloSeal in Post-Operative Joint Replacements

Retrospective & Prospective Evaluation/Analysis of Hb/Hct in Patients Having Received FloSeal (5ml &10ml) When Undergoing Total Knee or Total Hip Arthroplasty

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Desert Orthopedic Center Medical Research Foundation · Academic / Other
Sex
All
Age
18 Years – 95 Years
Healthy volunteers
Not accepted

Summary

The purpose of this analysis is to compare Hemoglobin and Hematocrit levels following total hip or knee arthroplasty. The utilization of FloSeal intraoperatively will improve hemostasis postoperatively. Decreasing bleeding time will decrease the drop in level of Hemoglobin and Hematocrit which usually occurs postoperatively.

Detailed description

Retrospective Analysis of charts on patients having undergone Total Hip or Total Knee Arthroplasty. During the patient's hospitalization, lab values of Hg and Hct will be recorded for further analysis. Preoperative levels will be also noted to establish baselines. Primary Data interest will be Hemoglobin (Hgb) level documented during hospitalization along with Hematocrit (HCT) and Red Blood Cell (RBC) data also collected. Secondary Data gathered will consist of the following: * patient Demographics * Component Profile * Length of Stay * Anesthesia used * Anesthesiologist * EBL * drain type * Amount of drainage fluid recorded at 12 hour increments until discharge * Amount of FloSeal used * Type of Arthroplasty 500 patients in Total * 100 Historical Control Patients, knees - no FloSeal (retrospective) * 100 Patients, knees - 5mL FloSeal (retrospective) * 100 Patients, knees- 10mL FloSeal (prospective) * 100 Historical Control patients, hips-no FloSeal (retrospective) * 100 retrospective patients, hips-5mL of FloSeal (retrospective Patients scheduled for Total Knee Arthroplasty will be asked if they wish to participate in the part of the study utilizing 10mL of FloSeal. These patient will be consented and the their data will be retrospectively gathered.

Conditions

Timeline

Start date
2009-09-01
First posted
2009-08-14
Last updated
2009-08-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00958945. Inclusion in this directory is not an endorsement.